SCOPE 2018
Medrio expanding globally following $30m investment
The healthcare technology company Medrio is expanding its business both internationally and domestically following a $30m investment – and demand knocking on its door.
SCOPE 2018
The healthcare technology company Medrio is expanding its business both internationally and domestically following a $30m investment – and demand knocking on its door.
Amulet Capital Partners – owner of SynteractHCR – is expanding its presence in the outsourced pharmaceutical services industry, with a recent investment in the medical communications provider Peloton Advantage.
Axim says its proprietary methods to extract and microencapsulate cannabinoid molecules make purer active pharmaceutical ingredients than traditional methods.
Roche will use Emulate’s Human Emulation System to better predict the safety and efficacy of its drug candidates.
Standardization in preclinical animal studies may be a cause of poor reproducibility – making translation to humans in clinical trials difficult, if unlikely, say researchers.
Toyama Chemical’s facility will support trials of lipsome drugs produced using technologies cultured through Fujifilm’s photographic film business.
BIOPHARMA AMBITION 2018
Tax policy reforms have made the US and UK attractive locations for drugmaker investment, says PwC’s Jean Delaney, but argued Ireland is “still well positioned on the tax front.”